SCOTTSDALE, Ariz. (AP) --- Authorities say seven people are being treated for burns after some sort of explosion at the Taser International plant in north Scottsdale. Scottsdale Fire Department officials say one man was transported from the scene in critical condition Thursday while six others were hospitalized in stable condition. It wasn't immediately clear if all of the injured were Taser employees.
Seattle Genetics participates in a conference call with Leerink
Leerink holds a conference call with CEO Siegall, CFO Simpson and COO Dobmeier on September 10 at 11 am.
NYPD contracting to spend up to $4.5M on TASER weapons, NY Post says
The NYPD is contracting to spend up to $4.5M on nonlethal weapons from TASER, according to The NeYork Post
A couple of thoughts. First of all, the acquisition took place in Q3 and should not effect Q2 earnings. And, secondly, the acquisition telegraphs the need for additional personnel and resources in the UK needed to implement the large pending order of body cams mentioned a couple of months ago. A good thing. And, finally, the acquisition eliminates the 'middle man' on UK sales and will increase margins on the huge pending UK body cam order. To have sold off on this news is ridiculous. This is a buying opportunity for those looking to establish a position in TASR.
Fresno council approves $2.5M for police body cameras, ABC30 reports
Fresno's city council approved more than $2.5M for use in buying 400 body cameras for its police force and will also buy 400 new taser guns from the same company, reported ABC30
gilman. Thanks for that great post. I think you have it exactly right. Law enforcement is going through a true paradigm shift and tasr is right at the heart of it. That is a rare situation. Now, managing the growth is going to be the challenge. I spend my winters in Scottsdale and consequently picked up early on tasr from local reporting. All long holders should do very well. Tasr has been good to me. Thanks again for the post. Have a nice weekend, everybody.
Maryland gov to sign police body camera bill, Washington Post says
Maryland's Republican Governor, Larry Hogan, said he would sign a bill directing the state's police training commission to develop and implement a policy for police to use body cameras, according to The Washington Post. Hogan's decision comes after a Baltimore man died while in police custody, sparking protests in the city. Baltimore's mayor has been lukewarm about the possibility of equipping the city's police force with body cameras.
Expert upbeat on Seattle Genetics Adcetris, says RBC Capital
After meeting with an expert, RBC Capital reports that he believes that off-label use of Seattle Genetics' Adcetris is increasing across a variety of indications. He believes that Adcetris is approvable and has a better chance of becoming a front-line treatment than competing drugs. The firm keeps a $50 price target and Outperform rating on the shares.
rosetta. It's refreshing to read an 'adult' post on these boards. I suppose I am about where you are with XOMA, having had a position for only a few months. My past experience bio has been with Seattle Genetics and it has done very well over the years for me. (I also own CLDX and IMGN as I am a believer in ADC methodology) My 'canary in the coal mine' on these biotechs is the Baker Bros. When I learned of their position in XOMA, I followed suit. I would like to know more about the company, like you, but do see a few things that I like. First of all, many of these biotech companies are not adequately funded initially. Research and trials burn cash at alarming rates and many simply run out of money, need to issue additional shares, and dilute the existing shareholders. XOMA, with their recent offering and placement seems to be in a good cash position for some time. I find that reassuring as far as the investment goes. I like the fact that they stated that they have 2 phase III trials underway which, given they meet endpoints and objectives, could be huge catalysts in the near term.
I was wondering the same thing when I saw that item. But, I would think any new 'science' could take years to get through the FDA. It does address the same cancers SGEN is working on.
This morning, the doctors were asked about knee replacements, options, and the best alternative. Without hesitation, the doctor mentioned Makoplasty as being the best alternative including total knee replacement.
TASER announces X2, X26 CEW orders
TASER announced several significant orders for more than 409 TASER Smart Weapon Platforms and 955 TASER X26 Conducted Electrical Weapons, or CEWs, along with various related equipment. Smart TASER CEW orders include Sunnyvale Department of Public Safety order for 210 TASER X26P CEWs, Richmond County Sheriff's Office order for 136 TASER X2 CEWs, Tulsa Police Department order for 33 X2s, and Garfield County Sheriff's Office order for 30 X2s. TASER X26 CEW orders include United Kingdom orders for 100 X26s, 16,000 TASER cartridges and 6,000 XDPMs, U.S. Army order for 500 X26s, Philadelphia Police Department, PA order for 225 X26s, and unnamed U.S. federal law enforcement agency order for 130 X26s and 24,720 TASE R cartridges. These orders are expected to ship in the first half of 2013.
August 9, 2012
07:58 EDT SGEN theflyonthewall.com: Seattle Genetics shares should be bought on weakness, says RBC Capital
RBC Capital believes that Seattle Genetics' flat Adcetris sales could raise concerns about the drug's outlook. But the firm thinks that the company's guidance is achievable, while the company should remain a core biotech holding. :theflyonthewall.com
If you actually care to know what trials Seattle Genetics are engaged in, follow the link and type in 'Seattle Genetics'. This is what you will find.
Found 74 studies with search of: